Medication-Assisted Treatment

Evidence-based medicine for opioid and alcohol use disorder — never offered alone.

Medication-Assisted Treatment is the most studied, most effective intervention in modern addiction medicine. At Valor Health we offer the complete FDA-approved spectrum — and we always pair it with the therapy, psychiatry and family work that makes long-term recovery real.

(XXX) XXX-XXXX Book a confidential assessment

MAT is not 'trading one drug for another.' It is treating a chronic medical condition with proven medicine.

FDA-approved options

50%

Lower overdose death rate*

Daily

Psychiatric oversight

Yes

Insurance covered

Section 01

Why MAT works

Opioid and alcohol use disorders cause measurable, lasting changes in brain receptors that drive cravings, withdrawal sensitivity and relapse risk for months or years after the last use. MAT medications stabilize those receptor systems — eliminating cravings, blocking the high if relapse occurs, or making alcohol physically unpleasant. The result: patients have the cognitive and emotional bandwidth to actually do the work of therapy and recovery.

Reduces cravings and withdrawal
Blocks reinforcement of relapse
Significantly lowers overdose death risk
Frees mental bandwidth for therapy

Section 02

Buprenorphine — Suboxone & Sublocade

Buprenorphine (the active ingredient in Suboxone, taken daily) and its long-acting injectable form Sublocade (monthly) are first-line for opioid use disorder. They partially activate opioid receptors enough to eliminate withdrawal and cravings without producing a high. Most patients feel essentially normal — clear, functional, no euphoria, no withdrawal. Our prescribers are X-waivered and experienced with fentanyl micro-induction protocols.

Suboxone (daily film/tablet)
Sublocade (monthly injection)
Fentanyl micro-induction expertise
No fixed timeline — taper or maintain

Naltrexone and Vivitrol treatment options

Section 03

Naltrexone & Vivitrol

Naltrexone (oral, daily) and Vivitrol (extended-release monthly injection) block opioid receptors entirely — if you use opioids while on Vivitrol, nothing happens. This is the right choice for patients who want a non-opioid option, who have completed detox and want a relapse-prevention safety net, or who are facing high-risk transitions (returning home, leaving residential, etc.). Vivitrol is also FDA-approved for alcohol use disorder.

Vivitrol (monthly injection)
Oral naltrexone (daily)
Effective for both opioid & alcohol use
Non-opioid, non-controlled

Section 04

Acamprosate, Disulfiram & alcohol

For alcohol use disorder we offer the full medication toolkit. Acamprosate (Campral) reduces post-acute withdrawal symptoms and supports brain recovery. Disulfiram (Antabuse) makes drinking physically aversive — a powerful relapse-prevention tool in the right patient. Naltrexone (oral or Vivitrol) reduces craving and reward. We match the medication to the patient's biology, goals and history.

Acamprosate for post-acute withdrawal
Disulfiram for relapse prevention
Naltrexone / Vivitrol for craving
Gabapentin & topiramate as adjuncts

Section 05

MAT is never the whole plan

We do not run a MAT-only clinic. Every MAT patient receives individual therapy, group therapy, psychiatric oversight, family work, and access to our full continuum of care. Medications open the door; therapy walks you through it. Patients who try MAT-only approaches have far worse long-term outcomes than those who combine MAT with real psychosocial treatment.

MAT + individual therapy weekly
MAT + group therapy multiple/week
MAT + psychiatric oversight
MAT + family programming

Long-term aftercare and collaborative decision making

Section 06

Long-term MAT or taper — your choice, your timeline

We do not impose a timeline on MAT. Some patients stay on buprenorphine or Vivitrol for years, just as someone with hypertension stays on blood pressure medication. Others taper after 12–24 months once recovery is solid. The decision is collaborative, clinical, and informed by your goals — never arbitrary, never financial. Long-term MAT is good medicine; tapering well is also good medicine.

No mandatory taper timeline
Annual collaborative re-evaluation
Slow medically supervised tapers
Continued therapy through transitions

Take the next step

Take the next step.

Confidential help, available 24 hours a day. Verify insurance and ask about MAT options.

*Overdose data: NIDA / SAMHSA peer-reviewed studies.

Call now Begin admissions